Absci (ABSI) Amortization of Goodwill (2023)

Absci's (ABSI) quarterly Amortization of Goodwill came in at $21.3 million in Q2 2023.

Absci (ABSI) Amortization of Goodwill (2023) Analysis & Trends

Absci has disclosed Amortization of Goodwill across 1 years of filings, most recently posting $21.3 million for Q2 2023.

Amortization of Goodwill for Q2 2023 came in at $21.3 million, changed N/A year-over-year; the trailing twelve-month figure through Jun 2024 was $21.3 million (changed 0.0% YoY), and the FY2023 annual result was $21.3 million, changed N/A from the prior year.
Amortization of Goodwill came in at $21.3 million for Q2 2023 at Absci.
In the past five years, Amortization of Goodwill ranged from a high of $21.3 million in Q2 2023 to a low of $21.3 million in Q2 2023.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Alterity Therapeutics	925,601.88 Bn	925,601.85 Bn	-
2	Belite Bio	58,560.00 Bn	58,560.00 Bn	-
3	Quantum Biopharma	17,284.41 Bn	17,284.40 Bn	-
4	Legend Biotech	2,809.00 Bn	2,808.71 Bn	242.10 Mn
5	Evaxion A	1,334.43 Bn	1,334.42 Bn	-
6	Akari Therapeutics	1,312.27 Bn	1,312.26 Bn	-
7	Psyence Biomedical	212.16 Bn	212.16 Bn	-
8	Vertex Pharmaceuticals	114.83 Bn	107.58 Bn	2.59 Bn
9	Abivax	91.96 Bn	91.96 Bn	-
10	Absci	1.13 Bn	1.01 Bn	-

Download Data

Date	Value
Jun 30, 2023	21.30 Mn
Jun 30, 2023	21.30 Mn